Application of pdia3p1 as a prognostic marker in glioma
A technology for prognostic markers and glioma, which is applied in the determination/testing of microorganisms, medical preparations containing active ingredients, antineoplastic drugs, etc. It can solve the problems of invasion and reduce HCC cell migration, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 11
[0115] Example 1 1. Materials and methods
[0116] 1.1 Data set acquisition
[0117] The microarray data set uses the Illumina Human HT-12 V3.0 platform to download the public U87MG glioma cell line microarray gene map data set GSE45301 from Gene Expression Omnibus (GEO). The RNA sequencing data of tumor tissue samples were obtained from TCGA (https: / / cancergenome.nih.gov) and CGGA (http: / / www.cgga.org.cn / ), respectively. The cutoff values for high and low PDIA3P1 expression were set as the expression level of the median sample. Clinical attributes are downloaded from the TCGA dataset. Enrichment analysis The gene expression profiles in the TCGA dataset were correlated with the biological process (BP) of Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and PDIA3P1. Differentially expressed genes (DEGs) were detected with the DESeq2 package of R, and the genes with significant differences were defined as |log2FC|≥2, p<0.05. DEGs were enriched and analyze...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com